Thomas Bieringer

Technical Leader at Bayer

Cologne Bonn Region

About

International leadership experience of over 20 years in Technology-, Innovation-, Alliance- Management and Business Development with track record in Material & Life Sciences

Experience

  • Bayer Pharmaceuticals (11 yrs 7 mos)
    • Advanced pharmaceutical manufacturing technologies
      Oct 2020 - Present · 5 yrs 9 mos

      Leading a global competency center for biochemical & bioprocess engineering to • shape definition & implementation of new Cell & Gene Therapy development and manufacturing platform • support pipeline realization & troubleshooting activities by providing state-of-the-art technology solutions

    • Engineering & Technology, Unit Head Process Technologies
      Jan 2017 - Sep 2020 · 3 yrs 9 mos

      • Functional lead of a center-of-excellence for process engineering for optimization and scale-up of chemical production processes for all Bayer Divisions • Head of Bayer’s cross-divisional Process Technology Community • Working areas: reaction-, reactor-, thermal & mechanical process- engineering, formulation technologies, modelling & simulation of processes and plants

    • Bayer Technology Services, Unit Head Upstream Processes
      Dec 2014 - Dec 2016 · 2 yrs 1 mo

      • Functional lead of a center-of-excellence for biotechnological and chemical process engineering, physical chemistry, physics and equipment design • Working areas: reaction and reactor engineering; fermentation; cell-culturing; bio-catalysis and biotransformation; conti-, photo- and electro-chemistry • Supervision of INVITE GmbH

  • Founder and Managing Director of INVITE GmbH at INVITE GmbH
    Jul 2011 - Aug 2015 · 4 yrs 2 mos

    R&D center and open innovation platform for innovative production technologies for the chemical and pharmaceutical industry; Public-Private Partnership between Bayer and TU Dortmund University • Start-up, commercial, strategic and technical lead of the company • Establishment of a network of over 70 business and development partners • Definition and execution of a project portfolio comprising innovative and sustainable production approaches for chemical and biological products, concepts for CO2 conversion, new digital and robotics application in production and supply-chain • Realization of public funding projects with an overall budget of ~ € 100 Mio. • Successful technical and economic proof-of-concept of modular chemical production plants and industrial realization of first pilots • Definition and introduction of industry standards for modular production plants

  • Bayer (14 yrs 3 mos)
    • SVP Corporate Development – Innovation
      May 2004 - Jun 2011 · 7 yrs 2 mos

      • Chairman of Bayer’s global R&D community - Head of decision body for group-wide innovation / IP- topics - Steering of cross-group projects, initiatives and best practice exchange • Counsel board of management on technology-, and innovation- related topics - Unbiased assessment of key R&D-, as well as related M&A- projects - Initiate projects to assess major technology trends - Organization of technology advisory panels with external key opinion leaders • Definition of an innovation strategy for the Bayer Group - Support development of the business-group’s innovation strategies, highlights: integration of Schering’s research into Bayer; scoping of the CropScience biotechnology platform, definition of MaterialScience’s Functional Films franchise - Assessment of R&D performance & strategy in the annual strategy conferences • Responsibility for corporate innovation politics - Advice of governmental bodies during definition of public research agenda, highlight: shaping the Hightech Strategy of the German government

    • Department Head Physics and Characterization at Bayer Polymers
      Aug 2002 - Apr 2004 · 1 yr 9 mos

      Global functional lead of polymer analytics, testing centers, development programs for optimization of physical and processing properties of coatings, functional films, thermoplastic polymers, polyurethanes, rubbers • Merging groups of former business-units in one integrated department and thereby realization of 30% synergies • Shift from pure service-provider to interdisciplinary co-operation partner within BPO as well as with main customers to tailor material properties to market needs • Development and implementation of innovative hard- and software methods to analyze, predict and optimize polymer properties

    • Group Head Biophysics, Physical Methods of Drug Discovery
      Mar 2000 - Jul 2002 · 2 yrs 5 mos

      • Set-up and functional lead of an interdisciplinary R&D group • Scope: development of new hard- and software tools to further increase efficiency in pharmaceutical and agrochemical R&D, as well as innovative diagnostics devices Project highlights: • Imaging and high-throughput screening devices for active ingredients implemented in Bayer’s Pharma and Agrochemical Divisions • Electro-optical biosensors for food-quality tests in agrochemical industry • Utilization of pharmacokinetic simulation software to determine the ideal dosage of pharmaceutical drug development candidates

  • Marketing Manager at SENTECH Instruments GmbH
    Sep 1996 - Mar 1997 · 7 mos

    Optical laboratory equipment for polymer and semiconductor industry

  • PhD Thesis in Physics at Universität Bayreuth
    May 1994 - Aug 1996 · 2 yrs 4 mos

    University of Bayreuth: Institute of Experimental Physics & Bayreuth Institute of Macromolecular Research, University of Massachusetts, Amherst, USA: Institute for Polymer Science Optical and electro-optical properties of liquid-crystalline polymers, spectroscopy, holographic data storage